Health Industries: U.S. Deals Outlook for 2025 and Beyond

Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:

Key topics include:

• A look back at M&A activity in health industries in 2024
• The challenges and potential impediments that could affect deal volumes in the coming year
• How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
• Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors

Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC

Linked materials:

• https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
• https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.